Joel Austin

Joel Austin

Company: Seed Therapeutics

Job title: Senior VP of Platform Technology Development


Photochemicalbiology for the Identification of Basal E3:POI Interactome 9:30 am

• Known molecular glues for TPD increase the avidity of a weak basal interaction between an E3 Ligase and a Protein of Interest • A broadly robust technology to identifying these weakly productive basal interactions in a cellular context does not exist. Thus the discovery of molecular glues has historically been serendipitous • Seed has…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.